Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flavonoid-rich fraction from Bacopa floribunda (FBF) is a botanical extract derived from the medicinal plant *Bacopa floribunda* (R.Br.) Wettst, which is traditionally used as a cognitive enhancer. FBF is being investigated for its neuroprotective, antioxidant, and anti-inflammatory properties in preclinical models of Alzheimer's disease. In animal models of amyloid-beta (Aβ1-42)-induced dementia, FBF has been shown to ameliorate amyloidogenesis, reduce phosphorylated tau (P-tau) and acetylcholinesterase (AChE) levels, suppress microgliosis, and increase brain-derived neurotrophic factor (BDNF) expression, thereby mitigating cognitive deficits and neuroinflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on flavonoid-rich fraction from Bacopa floribunda.